Home / Health / India's Dengue Crisis: Multiple Strains Fueling Risk

India's Dengue Crisis: Multiple Strains Fueling Risk

Summary

  • India faces hyperendemic dengue transmission with multiple virus strains.
  • DENV-2 is the dominant strain, with co-infections increasing.
  • Effective dengue vaccines face challenges due to multiple circulating serotypes.
India's Dengue Crisis: Multiple Strains Fueling Risk

India's dengue epidemic has entered a more complex phase characterized by the simultaneous circulation of multiple virus strains across the country. A recent nationwide surveillance study by the ICMR's VRDL indicates this hyperendemic transmission pattern, raising concerns about increased risk of severe illness and unpredictable outbreaks.

The study analyzed nearly 7,000 dengue samples from 2023 to 2025, finding that eight states had all four serotypes circulating concurrently. DENV-2 emerged as the dominant strain nationally, accounting for over half of infections. Notably, about 7% of patients were simultaneously infected with multiple dengue serotypes, a condition associated with higher risks of thrombocytopenia and hemorrhagic manifestations.

Dengue, a mosquito-borne viral disease, is prevalent in tropical regions and presents with symptoms like high fever and severe body aches. Infection with one serotype confers only temporary immunity to others, increasing the likelihood of repeated infections and severe dengue, especially with a second, different serotype. There is no specific antiviral treatment, with management focusing on supportive care.

This hyperendemic situation poses significant challenges for public health. It increases the probability of secondary infections, known to carry a higher risk of severe disease. Furthermore, the emergence of concurrent infections with multiple serotypes requires closer monitoring by clinicians. The study underscores the critical need for continuous national molecular surveillance to anticipate shifts in disease patterns and inform preparedness measures.

Developing effective dengue vaccines is also complicated by the presence of multiple circulating serotypes. A successful vaccine must provide balanced immunity against all four strains. As India considers its Universal Immunisation Programme, ongoing monitoring of circulating serotypes will be crucial for informing vaccination policies and assessing vaccine performance over time. This evolving landscape, influenced by viral evolution and changing transmission dynamics, demands a dynamic approach to dengue control.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Read more news on

Property Code: 5571